You are here

Objective measures of speech post-L-dopa & STN DBS in PD

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41NS047959-01
Agency Tracking Number: NS047959
Amount: $380,053.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
SPEECH TECHNOLOGY AND APPLIED RESEARCH CORPORATION
Bedford, MA 01370
United States
DUNS: N/A
HUBZone Owned: Unavailable
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
  Vanhorne
 (617) 732-8891
 CVANHORNE@PARTNERS.ORG
Business Contact
Phone: (781) 861-7827
Email: JoelM@S-T-A-R-corp.com
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Speech is a complex motor behavior often disrupted by neurologic dysfunction. Parkinson's disease (PD) is one of the most prominent neurological disorders associated with speech disturbances. L-dopa continues to be the

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government